https://consumer.healthday.com/canagliflozin-physician-s-briefing-2664003245.html
0
0
26 words
0
Comments
Increase in biomarkers and multimarker panel linked to increased risk for primary cardiorenal outcome
You are the first to view
Create an account or login to join the discussion